NHC
National HealthCare Corporation · Healthcare · Medical - Care Facilities
Momentum inputs (comparable managers):
holder breadth -12.5% ·
share flow -1.5% ·
net new positions -14.3%
· formula
Broad distribution: falling shares and fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q3 2025
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q3 2026 | 1 | 0 | 1.43K | $321,543 | n/a | n/a |
| Q2 2026 | 83 | +4 | 7.12M | $1.51B | +8 | −4 |
| Q1 2026 | 82 | -2 | 6.91M | $1.10B | +4 | −6 |
| Q4 2025 | 84 | 0 | 7.44M | $1.02B | +1 | −1 |
| Q3 2025 | 14 | -2 | 4.85M | $590.24M | n/a | −2 |
| Q2 2025 | 13 | +1 | 4.66M | $498.80M | +1 | n/a |
| Q1 2025 | 9 | +2 | 1.32M | $122.67M | +2 | n/a |
| Q4 2024 | 7 | -4 | 1.24M | $133.72M | n/a | −4 |
| Q3 2024 | 10 | +1 | 803.83K | $101.11M | +1 | n/a |
| Q2 2024 | 9 | n/a | 813.70K | $88.21M | n/a | n/a |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passive) | 1.88M | -1.2% | $228.79M | 0.0% | ▼ Trim | 2 | SEC ↗ ×13 |
| 2 | The Vanguard Group ✦ (passive) | 1.42M | -1.3% | $172.81M | 0.0% | ▼ Trim | 2 | SEC ↗ ×5 |
| 3 | State Street Global Advisors ✦ (passive) | 490.63K | -0.4% | $59.93M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 4 | Renaissance Technologies ✦ | 373.87K | -3.5% | $45.43M | 0.1% | ▼ Trim | 6 | SEC ↗ |
| 5 | Geode Capital Management ✦ (passive) | 316.08K | +1.7% | $38.41M | 0.0% | ▲ Add | 6 | SEC ↗ ×2 |
| 6 | JPMorgan Chase ✦ | 110.42K | n/a | $13.42M | 0.0% | n/c | 1 | SEC ↗ ×10 |
| 7 | Morgan Stanley ✦ | 98.13K | n/a | $11.92M | 0.0% | n/c | 1 | SEC ↗ ×7 |
| 8 | Goldman Sachs Group ✦ | 59.76K | n/a | $7.26M | 0.0% | n/c | 1 | SEC ↗ ×2 |
| 9 | Two Sigma Investments ✦ | 42.64K | -16.2% | $5.18M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 10 | AQR Capital Management ✦ | 26.83K | +105.9% | $3.26M | 0.0% | ▲ Add | 6 | SEC ↗ ×4 |
| 11 | Millennium Management ✦ | 12.21K | -31.5% | $1.48M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 8.82K | +8.3% | $1.07M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 13 | Arrowstreet Capital ✦ | 8.72K | +16.1% | $1.06M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 14 | Fidelity (FMR) ✦ | 1.70K | +74.0% | $206,528 | 0.0% | ▲ Add | 2 | SEC ↗ ×2 |
“Their weight” = the position's share of that manager's reported 13F equity value: the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Citadel Advisors | $1.23M | was 0.0% |
| Point72 Asset Management | $1.07M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 236 holders, 10.21M shares, $1.54B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold: shared-ownership counts, not fundamental relationships.
Open-market purchases (P)
No open-market insider purchases in our coverage window.
Open-market sales (S)
Officer · 4.83K sh · $1.09M
Officer · 6.81K sh · $1.54M
Officer · 1.29K sh · $290,587
Officer · 68 sh · $15,340
Officer · 571 sh · $127,181
Officer · 789 sh · $176,561
Officer · 1.00K sh · $222,500
Officer · 1.00K sh · $227,000
Director · 1.78K sh · $401,022
Officer · 1.00K sh · $237,000
Awards, exercises and tax withholding are never counted as buys or sales here. Methodology